Fuchen Xie

No ORCID on file · 2 papers in corpus
review 2025
Frontiers in bioengineering and biotechnology ·doi:10.3389/fbioe.2025.1697669

Thin endometrium is one of the main factors leading to infertility and miscarriage. The development of biomaterial technology and its clinical applications have shown good effects in promoting endometrial regeneration, improving blood flow,…

lab-animal 2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.874973

Relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, has been well studied in the treatment of endometriosis symptomatic. It is mainly metabolized by the CYP3A subfamily of P450 enzymes, while minorly metabolized by CYP2C…